<code id='A63D036216'></code><style id='A63D036216'></style>
    • <acronym id='A63D036216'></acronym>
      <center id='A63D036216'><center id='A63D036216'><tfoot id='A63D036216'></tfoot></center><abbr id='A63D036216'><dir id='A63D036216'><tfoot id='A63D036216'></tfoot><noframes id='A63D036216'>

    • <optgroup id='A63D036216'><strike id='A63D036216'><sup id='A63D036216'></sup></strike><code id='A63D036216'></code></optgroup>
        1. <b id='A63D036216'><label id='A63D036216'><select id='A63D036216'><dt id='A63D036216'><span id='A63D036216'></span></dt></select></label></b><u id='A63D036216'></u>
          <i id='A63D036216'><strike id='A63D036216'><tt id='A63D036216'><pre id='A63D036216'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:6942
          Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT
          Adobe

          There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

          Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

          advertisement

          Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Medicare explains how it will choose drugs for negotiation

          Medicarelaidoutinthegreatestdetailyethowitwillchoosewhichdrugpricesitwillnegotiateinitsbrand-newprog